Physician profile
Dana Lin
NPI 1811481914
$15,124.43
in general payments reported to CMS, 2019-2025
30 companies · $640 in 2025
The $640 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,592 · 2020: $392 · 2021: $1,150 · 2022: $2,473 · 2023: $4,260 · 2024: $3,616 · 2025: $640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,656 · Travel and Lodging: $2,848 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,656.26 |
| Travel and Lodging | $2,848.43 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,818.60 | 2019-2024 | Viaflow, Prostep, Augment Injectable |
| Paragon 28, INC. | $3,400.06 | 2019-2025 | Portfolio, Grappler, Additive Orthopedics |
| Integra Lifesciences Corporation | $1,489.39 | 2019-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Arthrex, INC. | $1,242.90 | 2022-2024 | |
| Treace Medical Concepts, INC. | $1,197.89 | 2022-2025 | |
| Smith+Nephew, INC. | $510.99 | 2021-2023 | Evos, Pico, Salto Talaris Total Ankle Prosthesis |
| Gilead Sciences, INC. | $411.17 | 2023-2025 | Epclusa, Biktarvy, Yeztugo |
| Inari Medical, INC. | $402.95 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Biotissue Holdings INC. | $346.80 | 2021-2024 | |
| Linvatec Corporation | $211.85 | 2023-2024 | Biobrace 23mm, 5ms |
| Medical Device Business Services, INC. | $209.99 | 2019 | |
| Depuy Synthes Sales INC. | $183.02 | 2019-2024 | |
| Trimed, INC. | $178.23 | 2024 | |
| Paratek Pharmaceuticals, INC. | $165.84 | 2024 | Nuzyra |
| Horizon Therapeutics Plc | $160.30 | 2023 | Krystexxa |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $149.78 | 2023 | Eterna |
| In2bones USA, LLC | $145.60 | 2022 | |
| Novo Nordisk INC | $140.51 | 2024-2025 | Wegovy |
| Merck Sharp & Dohme LLC | $127.20 | 2019-2025 | Capvaxive, Gardasil 9 |
| Amgen INC. | $121.84 | 2024 | Krystexxa |
| Organogenesis INC. | $101.04 | 2021 | |
| Averitas Pharma INC. | $100.36 | 2023 | Qutenza |
| Saxum Surgical, INC. | $61.38 | 2023-2025 | |
| Dexcom, INC. | $58.45 | 2024 | Dexcom G6 Transmitter |
| Conmed Corporation | $56.46 | 2023 | 5ms |
| Zimmer Biomet Holdings, INC. | $50.33 | 2021 | |
| Tactile Systems Technology INC | $38.26 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $18.37 | 2020 | |
| Acell, INC. | $15.75 | 2019 | |
| Aroa Biosurgery Incorporated | $9.12 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.